NCT00904462 - Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee | Biotech Hunter

Enrollment

224

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

September 30, 2005

Conditions

Osteoarthritis, Knee

Interventions

DRUG

Lidoderm

Eligible patients were randomly allocated to receive one of two treatments for 12 weeks: lidocaine 5% patch or matching placebo patch.

DRUG

Placebo patch

Eligible patients were randomly allocated to receive one of two treatments for 12 weeks: lidocaine 5% patch or matching placebo patch.

Trial Locations (24)

Birmingham

Hueytown

Tallassee

Phoenix

Boulder

DeLand

Largo

Palm Harbor

St. Petersburg

Chicago

Springfield

Wheaton

Peabody

Bingham Farms

Reno

Berlin

Dayton

Oklahoma City

Duncansville

Philadelphia

Charleston

Bartlett

Cordova

Memphis